Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Cheng Guo

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Oncotarget|June 25, 2016
Treatment of primary intracranial germ cell tumors: Single center experience with 42 clinically diagnosed casesQun-Ying Yang, Cheng-Cheng Guo, Mei-Ling Deng, et al.
Oncology Reports|September 3, 2015
Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cellsDong Shen, Cheng-Cheng Guo, Jing Wang, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2020
Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive gliomaXiang-Rong Ni, Cheng-Cheng Guo, Yan-Jiao Yu, et al.
Stem Cells Translational Medicine|March 16, 2017
β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1Hai-Bin Feng, Jing Wang, Hao-Ran Jiang, et al.
Oncotarget|October 21, 2015
IDH1 mutation detection by droplet digital PCR in gliomaJing Wang, Yi-ying Zhao, Jian-feng Li, et al.
Journal of Neuro-Oncology|January 13, 2017
Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomasZhen-Qiang He, Chao Ke, Fuad Al-Nahari, et al.
BMC Cancer|August 26, 2014
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2Yan-chang Sun, Jing Wang, Cheng-cheng Guo, et al.
Frontiers in Pharmacology|October 26, 2020
Prognostic Value of the Modified Systemic Inflammation Score in Patients With Extranodal Natural Killer/T-Cell LymphomaHe Huang, Li Min Chen, Xiao Jie Fang, et al.
Chemotherapy|November 18, 2024
Phase I Clinical Study of a Multi-Kinase Inhibitor TG02 Capsule for the Treatment of Recurrent High-Grade Gliomas with Failed Temozolomide Treatment in Chinese PatientsCheng-Cheng Guo, Qun-Ying Yang, Shao-Yan Xi, et al.
Cell Death & Disease|November 23, 2019
Tenascin-cmediated vasculogenic mimicry formation via regulation of MMP2/MMP9 in gliomaHai-Ping Cai, Jing Wang, Shao-Yan Xi, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Oncotarget|June 25, 2016
Treatment of primary intracranial germ cell tumors: Single center experience with 42 clinically diagnosed casesQun-Ying Yang, Cheng-Cheng Guo, Mei-Ling Deng, et al.
Oncology Reports|September 3, 2015
Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cellsDong Shen, Cheng-Cheng Guo, Jing Wang, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2020
Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive gliomaXiang-Rong Ni, Cheng-Cheng Guo, Yan-Jiao Yu, et al.
Stem Cells Translational Medicine|March 16, 2017
β-Elemene Selectively Inhibits the Proliferation of Glioma Stem-Like Cells Through the Downregulation of Notch1Hai-Bin Feng, Jing Wang, Hao-Ran Jiang, et al.
Oncotarget|October 21, 2015
IDH1 mutation detection by droplet digital PCR in gliomaJing Wang, Yi-ying Zhao, Jian-feng Li, et al.
Journal of Neuro-Oncology|January 13, 2017
Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomasZhen-Qiang He, Chao Ke, Fuad Al-Nahari, et al.
BMC Cancer|August 26, 2014
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2Yan-chang Sun, Jing Wang, Cheng-cheng Guo, et al.
Frontiers in Pharmacology|October 26, 2020
Prognostic Value of the Modified Systemic Inflammation Score in Patients With Extranodal Natural Killer/T-Cell LymphomaHe Huang, Li Min Chen, Xiao Jie Fang, et al.
Chemotherapy|November 18, 2024
Phase I Clinical Study of a Multi-Kinase Inhibitor TG02 Capsule for the Treatment of Recurrent High-Grade Gliomas with Failed Temozolomide Treatment in Chinese PatientsCheng-Cheng Guo, Qun-Ying Yang, Shao-Yan Xi, et al.
Cell Death & Disease|November 23, 2019
Tenascin-cmediated vasculogenic mimicry formation via regulation of MMP2/MMP9 in gliomaHai-Ping Cai, Jing Wang, Shao-Yan Xi, et al.
Pageof 4